Actively Recruiting

Phase Not Applicable
Age: 3Months - 4Years
All Genders
NCT02691858

Effect of Hydrocortisone on Improving Outcome of Pneumatic Reduction of Infantile Intussusception

Led by Cairo University · Updated on 2024-08-27

80

Participants Needed

1

Research Sites

556 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Intussusception is one of the most frequent causes of acute bowel and second most common cause of acute abdominal pain in pediatric age .95 % of cases are idiopathic, the rest are either due to pathological lead point or post operative. Treatment of intussusception must start with medical resuscitation, then radiological or operative reduction of intussusception. Our surgery team has used hydrocortisone with the medical resuscitation to improve the success rate of pneumatic reduction and decrease the number of reduction trials.

CONDITIONS

Official Title

Effect of Hydrocortisone on Improving Outcome of Pneumatic Reduction of Infantile Intussusception

Who Can Participate

Age: 3Months - 4Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Infantile Intussusception
Not Eligible

You will not qualify if you...

  • Peritonitis
  • Pneumoperitoneum
  • Morbid patients

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Cairo University Pediatric Hospital

Cairo, Egypt, 11432

Actively Recruiting

Loading map...

Research Team

M

Mostafa Gad, MSc

CONTACT

M

Mahmoud Elfiky, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

QUADRUPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here